Articles

Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasms

Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USA
Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USA;VA Puget Sound Health Care System, Seattle, WA, USA
LDS Hospital, Salt Lake City, UT, USA
Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USA
University of Liege, Belgium
Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USA
Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USA
Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USA
Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USA
Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USA
Vol. 104 No. 6 (2019): June, 2019 https://doi.org/10.3324/haematol.2018.199398